Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

L.A. McKeown

November 15, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

News Daily News

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

Shelley Wood

April 09, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

L.A. McKeown

May 11, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

News Daily News

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Michael O'Riordan

August 28, 2019

Advertisement

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

October 2023 News Roundup

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

PAD Significantly Ups Morbidity and Mortality in AMICS

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

Long-term Anticoagulation After Unprovoked VTE: New Insights

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content